GlaxoSmithKline | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 350.71B 19.93B 2025-05
Alcon AG CHF 38.43B 3.71B 2024-12
Almirall EUR 1.77B 232.92M 2024-12
Amgen USD 150.93B 16.57B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Biogen USD 17.99B 2.04B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
Fresenius EUR 24.33B 2.14B 2025-05
Fresenius Medical Care EUR 14.21B 806.3M 2025-05
Galapagos EUR 1.61B 75.03M 2025-05
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 128.54B 11.15B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
GRIFOLS EUR 3.6B 1.6B 2025-05
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
Lonza CHF 35.42B 9.08B 2024-06
Merck USD 208.29B 17.59B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Novo Nordisk A/S 2.12T 523.44B 2025-05
Orion EUR 6.01B 1.71B 2025-05
Pfizer USD 135.11B 8.61B 2025-05
Philips EUR 19.83B 2.15B 2025-05
Regeneron Pharmaceuticals USD 66.28B 3.05B 2025-05
Sanofi EUR 120.97B 4.87B 2025-05
Smith & Nephew GBP 8.67B 94.82M 2024-12



GlaxoSmithKline Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.